Sfoglia per Autore
Immunomodulatory effects of tyrosine kinase inhibitors (TKIs) in renal cell carcinoma (RCC) patients
2017 Nuti, M; Zizzari, I; Napoletano, C; Botticelli, A; Calabro, F; Gelibter, A; Rughetti, A; Ugolini, A; Ruscito, I; Mazzuca, F; Rahimi, H; Onesti, Ce; Cortesi, E; Marchetti, P
IgM-Rheumatoid factor confers primary resistance to anti-PD-1 immunotherapies in NSCLC patients by reducing CD137 + T-cells
2020 Ugolini, Alessio; Zizzari, ILARIA GRAZIA; Ceccarelli, Fulvia; Botticelli, Andrea; Colasanti, Tania; Strigari, Lidia; Rughetti, Aurelia; RAHIMI KOSHKAKI, Hassan; Conti, Fabrizio; Valesini, Guido; Marchetti, Paolo; Nuti, Marianna
Polymorphonuclear myeloid-derived suppressor cells limit antigen crosspresentation by dendritic cells in cancer
2020 Ugolini, A.; Tyurin, V. A.; Tyurina, Y. Y.; Tcyganov, E. N.; Donthireddy, L.; Kagan, V. E.; Gabrilovich, D. I.; Veglia, F.
Soluble Immune checkpoints, gut metabolites and performance status as parameters of response to Nivolumab treatment in NSCLC patients
2020 Zizzari, ILARIA GRAZIA; DI FILIPPO, Alessandra; Scirocchi, Fabio; DI PIETRO, FRANCESCA ROMANA; RAHIMI KOSHKAKI, Hassan; Ugolini, Alessio; Scagnoli, Simone; Vernocchi, Pamela; Del Chierico, Federica; Putignani, Lorenza; Rughetti, Aurelia; Marchetti, Paolo; Nuti, Marianna; Botticelli, Andrea; Napoletano, Chiara
IgM-rheumatoid factor as a novel biomarker for a reduced survival in anti-PD-1 treated NSCLC patients through the decrease of CD137+T-cells
2020 Ugolini, A; Zizzari, Ig; Ceccarelli, F; Botticelli, A; Colasanti, T; Strigari, L; Rughetti, A; Rahimi, H; Conti, F; Valesini, G; Marchetti, P; Nuti, M
Immunohistochemical characterization of immune infiltrate in tumor microenvironment of glioblastoma
2020 RAHIMI KOSHKAKI, Hassan; Minasi, Simone; Ugolini, Alessio; Trevisi, Gianluca; Napoletano, Chiara; Zizzari, Ilaria G.; Gessi, Marco; Giangaspero, Felice; Mangiola, Annunziato; Nuti, Marianna; Buttarelli, Francesca R.; Rughetti, Aurelia
Myeloid cells in glioblastoma microenvironment
2021 De Leo, A.; Ugolini, A.; Veglia, F.
Rheumatoid factor: a novel determiner in cancer history
2021 Ugolini, A.; Nuti, M.
DNA damage response and repair (DDR) gene mutations as an alternative mechanism to generate high TMB in never smoker NSCLC patients
2022 Filetti, M; Occhipinti, M; Cirillo, A; Scirocchi, F; Ugolini, A; Petti, M; Giusti, R; Lombardi, P; Botticelli, A; Lo Russo, G; De Braud, Fgm; Marchetti, P; Nuti, M; Ferretti, E; Rughetti, A; Farina, L
Circulating CD137 + T cells correlate with improved response to anti-PD1 immunotherapy in cancer patients
2022 Zizzari, Ig; Di Filippo, A; Botticelli, A; Strigari, L; Pernazza, A; Rullo, E; Pignataro, Mg; Ugolini, A; Scirocchi, F; DI PIETRO, FRANCESCA ROMANA; Rossi, E; Gelibter, A; Schinzari, G; D'Amati, G; Rughetti, A; Marchetti, P; Nuti, M; Napoletano, C.
Probing neutrophils heterogeneity in Glioblastoma: how the metabolism shapes the function of immunosuppressive CD71+Neutrophils
2023 Ugolini, Alessio
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Immunomodulatory effects of tyrosine kinase inhibitors (TKIs) in renal cell carcinoma (RCC) patients | 2017 | Nuti, M; Zizzari, I; Napoletano, C; Botticelli, A; Calabro, F; Gelibter, A; Rughetti, A; Ugolini, A; Ruscito, I; Mazzuca, F; Rahimi, H; Onesti, Ce; Cortesi, E; Marchetti, P | |
| IgM-Rheumatoid factor confers primary resistance to anti-PD-1 immunotherapies in NSCLC patients by reducing CD137 + T-cells | 2020 | Ugolini, Alessio; Zizzari, ILARIA GRAZIA; Ceccarelli, Fulvia; Botticelli, Andrea; Colasanti, Tania; Strigari, Lidia; Rughetti, Aurelia; RAHIMI KOSHKAKI, Hassan; Conti, Fabrizio; Valesini, Guido; Marchetti, Paolo; Nuti, Marianna | |
| Polymorphonuclear myeloid-derived suppressor cells limit antigen crosspresentation by dendritic cells in cancer | 2020 | Ugolini, A.; Tyurin, V. A.; Tyurina, Y. Y.; Tcyganov, E. N.; Donthireddy, L.; Kagan, V. E.; Gabrilovich, D. I.; Veglia, F. | |
| Soluble Immune checkpoints, gut metabolites and performance status as parameters of response to Nivolumab treatment in NSCLC patients | 2020 | Zizzari, ILARIA GRAZIA; DI FILIPPO, Alessandra; Scirocchi, Fabio; DI PIETRO, FRANCESCA ROMANA; RAHIMI KOSHKAKI, Hassan; Ugolini, Alessio; Scagnoli, Simone; Vernocchi, Pamela; Del Chierico, Federica; Putignani, Lorenza; Rughetti, Aurelia; Marchetti, Paolo; Nuti, Marianna; Botticelli, Andrea; Napoletano, Chiara | |
| IgM-rheumatoid factor as a novel biomarker for a reduced survival in anti-PD-1 treated NSCLC patients through the decrease of CD137+T-cells | 2020 | Ugolini, A; Zizzari, Ig; Ceccarelli, F; Botticelli, A; Colasanti, T; Strigari, L; Rughetti, A; Rahimi, H; Conti, F; Valesini, G; Marchetti, P; Nuti, M | |
| Immunohistochemical characterization of immune infiltrate in tumor microenvironment of glioblastoma | 2020 | RAHIMI KOSHKAKI, Hassan; Minasi, Simone; Ugolini, Alessio; Trevisi, Gianluca; Napoletano, Chiara; Zizzari, Ilaria G.; Gessi, Marco; Giangaspero, Felice; Mangiola, Annunziato; Nuti, Marianna; Buttarelli, Francesca R.; Rughetti, Aurelia | |
| Myeloid cells in glioblastoma microenvironment | 2021 | De Leo, A.; Ugolini, A.; Veglia, F. | |
| Rheumatoid factor: a novel determiner in cancer history | 2021 | Ugolini, A.; Nuti, M. | |
| DNA damage response and repair (DDR) gene mutations as an alternative mechanism to generate high TMB in never smoker NSCLC patients | 2022 | Filetti, M; Occhipinti, M; Cirillo, A; Scirocchi, F; Ugolini, A; Petti, M; Giusti, R; Lombardi, P; Botticelli, A; Lo Russo, G; De Braud, Fgm; Marchetti, P; Nuti, M; Ferretti, E; Rughetti, A; Farina, L | |
| Circulating CD137 + T cells correlate with improved response to anti-PD1 immunotherapy in cancer patients | 2022 | Zizzari, Ig; Di Filippo, A; Botticelli, A; Strigari, L; Pernazza, A; Rullo, E; Pignataro, Mg; Ugolini, A; Scirocchi, F; DI PIETRO, FRANCESCA ROMANA; Rossi, E; Gelibter, A; Schinzari, G; D'Amati, G; Rughetti, A; Marchetti, P; Nuti, M; Napoletano, C. | |
| Probing neutrophils heterogeneity in Glioblastoma: how the metabolism shapes the function of immunosuppressive CD71+Neutrophils | 2023 | Ugolini, Alessio |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile